Quantapore

Quantapore

Experience unprecedented speed and cost-efficiency with our innovative nanopore-based sequencing technology through quantum-optic interactions.

Founded 2009 Series C Total: $52.00M Biotechnology, Health Care

Quantapore is a biotech company founded in 2009 by Sascha C. Dennstedt and Martin Huber. The company specializes in advancing nanopore-based nucleic acid sequencing technology with a focus on Biotechnology and Health Care sectors. Quantapore's unique DNA sequencing technology utilizes an optically labeled nanopore that interacts through energy transfer with a labeled nucleic acid sample, enabling single molecule nucleic acid sequencing at unparalleled speed and cost. The company's slogan "Experience unprecedented speed and cost-efficiency with our innovative nanopore-based sequencing technology through quantum-optic interactions" speaks to the innovative nature of its approach. In July 19, 2018, Quantapore secured a significant $17.00M Series C investment from a consortium of investors including Foothill Ventures, Fusion Fund, Northern Light Venture Capital, Baidu Venture, and Sangel Capital. This capital injection is expected to further propel the development and commercialization of Quantapore's groundbreaking sequencing technology, positioning the company as a key player in the genomics and sequencing space.

Funding Stage	Amount	Investors	Lead Investors	Date
Series C	$17.00M	5	Foothill Ventures, Fusion Fund +3	19 Jul 2018
Series C	Undisclosed	1	China BioPharma Capital I	27 Sep 2016
Series B	$35.00M	-		21 May 2014
Seed Round	Undisclosed	-		01 Jan 2010

Funding Stage

Amount

Investors

Lead Investors

Date

Series C

$17.00M

Foothill Ventures, Fusion Fund +3

19 Jul 2018

Series C

Undisclosed

China BioPharma Capital I

27 Sep 2016

Series B

$35.00M

21 May 2014

Seed Round

Undisclosed

01 Jan 2010

FAQ About Quantapore

Experience unprecedented speed and cost-efficiency with our innovative nanopore-based sequencing technology through quantum-optic interactions.

Quantapore was founded in 2009.

Quantapore operates in Biotechnology and Health Care. Its work centres on biotech company, nanopore sequencing, DNA sequencing and optical readout.

Quantapore has completed 4 funding rounds, raising a total of $52.00M. The latest funding stage is Series C.

Top alternatives and competitors to Quantapore include Genia Technologies, Replicor Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Quantapore and Genia Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Quantapore

Funding Rounds & Investors (4)

Quantapore Alternatives & Competitors

FAQ About Quantapore